Caprock Group, Inc. Eli Lilly & CO Transaction History

Caprock Group, Inc.

$1.72 Billion
Q1 2024

A detailed history of Caprock Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Caprock Group, Inc. holds 10,740 shares of LLY stock, worth $9.74 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

10,740

Previous 9,936 8.09%

Holding current value

$9.74 Million

Previous $5.79 Million 44.28%

% of portfolio

0.49%

Previous 0.38%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$592.2 - $792.28 $476,128 - $636,993	804 Added 8.09%	10,740 $8.36 Million
Q4 2023 Jan 18, 2024	SELL	$525.19 - $619.13 $183,291 - $216,076	-349 Reduced 3.39%	9,936 $5.79 Million
Q3 2023 Oct 18, 2023	BUY	$434.7 - $599.3 $69,117 - $95,288	159 Added 1.57%	10,285 $5.52 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $216,055 - $288,891	616 Added 6.48%	10,126 $4.75 Million
Q1 2023 Apr 26, 2023	BUY	$310.63 - $364.82 $225,828 - $265,224	727 Added 8.28%	9,510 $3.27 Million

Q4 2022 Jan 23, 2023	BUY	$321.55 - $374.67 $184,891 - $215,435	575 Added 7.01%	8,783 $0
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $118,888 - $135,485	401 Added 5.14%	8,208 $2.65 Million
Q2 2022 Jul 26, 2022	BUY	$278.73 - $327.27 $273,712 - $321,379	982 Added 14.39%	7,807 $2.53 Million
Q1 2022 Apr 12, 2022	BUY	$234.69 - $291.66 $23,469 - $29,166	100 Added 1.49%	6,825 $1.96 Million
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $45,419 - $56,366	202 Added 3.1%	6,725 $1.86 Million
Q3 2021 Oct 07, 2021	BUY	$221.6 - $272.71 $256,391 - $315,525	1,157 Added 21.56%	6,523 $1.51 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $24,193 - $31,294	-134 Reduced 2.44%	5,366 $1.23 Million
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $40,751 - $52,754	-248 Reduced 4.31%	5,500 $1.03 Million
Q4 2020 Jan 29, 2021	SELL	$130.46 - $172.63 $41,355 - $54,723	-317 Reduced 5.23%	5,748 $970,000
Q3 2020 Oct 29, 2020	BUY	$146.22 - $169.13 $110,834 - $128,200	758 Added 14.28%	6,065 $898,000
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $148,424 - $178,627	-1,088 Reduced 17.01%	5,307 $871,000
Q1 2020 Apr 28, 2020	SELL	$119.05 - $147.35 $15,595 - $19,302	-131 Reduced 2.01%	6,395 $887,000
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $14,220 - $17,613	133 Added 2.08%	6,526 $858,000
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $73,685 - $80,150	-690 Reduced 9.74%	6,393 $715,000
Q2 2019 Jul 23, 2019	SELL	$110.79 - $129.32 $2,991 - $3,491	-27 Reduced 0.38%	7,083 $785,000
Q1 2019 Apr 12, 2019	SELL	$111.31 - $131.02 $264,361 - $311,172	-2,375 Reduced 25.04%	7,110 $923,000
Q4 2018 Jan 29, 2019	BUY	$105.9 - $118.64 $41,936 - $46,981	396 Added 4.36%	9,485 $1.1 Million
Q3 2018 Oct 17, 2018	SELL	$85.86 - $107.31 $7,298 - $9,121	-85 Reduced 0.93%	9,089 $975,000
Q2 2018 Jul 23, 2018	SELL	$75.7 - $86.88 $44,587 - $51,172	-589 Reduced 6.03%	9,174 $783,000
Q1 2018 Apr 23, 2018	SELL	$74.21 - $87.6 $90,833 - $107,222	-1,224 Reduced 11.14%	9,763 $755,000
Q4 2017 Jan 17, 2018	BUY	$81.94 - $87.89 $30,891 - $33,134	377 Added 3.55%	10,987 $956,000
Q3 2017 Oct 23, 2017	BUY	$77.07 - $85.54 $817,712 - $907,579	10,610	10,610 $908,000

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Eli Lilly & CO Transaction History